Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUORIMPA intra-articular opioids for chronic knee arthritis
2015-000538-31Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of morphine and triamcinolone acetonide in arthritis, knee osteoarthritis (OA), rheumatoid arthritis (RA) and 3 more (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Primary efficacy endpoint. Started Apr 2015; status: completed.
02
Drugs
morphinetriamcinolone acetonide
03
Conditions
arthritisknee osteoarthritis (OA)rheumatoid arthritis (RA)spondyloarthritis (SpA)monoarthritis
Beyond the preview
Go deeper on 2015-000538-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000538-31.